GLP1R and metabolic syndrome: In the current research mainstream, the considerable therapeutic potential of natural products is phenomenal in the treatment of MetS and its related complications, as highlighted by the rising interest in them as modulators of GLP-1 signaling and the TXNIP–thioredoxin system.